S&P 500   3,268.83 (+0.69%)
DOW   26,931.84 (+0.43%)
QQQ   267.95 (+0.96%)
AAPL   110.17 (+1.80%)
MSFT   206.05 (+1.41%)
FB   250.29 (+0.30%)
GOOGL   1,424.10 (+0.09%)
AMZN   3,040.11 (+0.67%)
TSLA   402.17 (+3.71%)
NVDA   504.79 (+2.20%)
BABA   267.86 (-0.69%)
CGC   14.06 (-1.47%)
GE   6.07 (+0.17%)
MU   48.31 (-2.34%)
AMD   76.59 (+1.02%)
T   27.86 (-0.64%)
F   6.54 (-1.80%)
ACB   5.00 (-3.85%)
GILD   61.92 (-0.53%)
NFLX   476.35 (+0.69%)
DIS   122.48 (+-0.01%)
BAC   23.34 (+0.00%)
BA   151.99 (+4.07%)
S&P 500   3,268.83 (+0.69%)
DOW   26,931.84 (+0.43%)
QQQ   267.95 (+0.96%)
AAPL   110.17 (+1.80%)
MSFT   206.05 (+1.41%)
FB   250.29 (+0.30%)
GOOGL   1,424.10 (+0.09%)
AMZN   3,040.11 (+0.67%)
TSLA   402.17 (+3.71%)
NVDA   504.79 (+2.20%)
BABA   267.86 (-0.69%)
CGC   14.06 (-1.47%)
GE   6.07 (+0.17%)
MU   48.31 (-2.34%)
AMD   76.59 (+1.02%)
T   27.86 (-0.64%)
F   6.54 (-1.80%)
ACB   5.00 (-3.85%)
GILD   61.92 (-0.53%)
NFLX   476.35 (+0.69%)
DIS   122.48 (+-0.01%)
BAC   23.34 (+0.00%)
BA   151.99 (+4.07%)
S&P 500   3,268.83 (+0.69%)
DOW   26,931.84 (+0.43%)
QQQ   267.95 (+0.96%)
AAPL   110.17 (+1.80%)
MSFT   206.05 (+1.41%)
FB   250.29 (+0.30%)
GOOGL   1,424.10 (+0.09%)
AMZN   3,040.11 (+0.67%)
TSLA   402.17 (+3.71%)
NVDA   504.79 (+2.20%)
BABA   267.86 (-0.69%)
CGC   14.06 (-1.47%)
GE   6.07 (+0.17%)
MU   48.31 (-2.34%)
AMD   76.59 (+1.02%)
T   27.86 (-0.64%)
F   6.54 (-1.80%)
ACB   5.00 (-3.85%)
GILD   61.92 (-0.53%)
NFLX   476.35 (+0.69%)
DIS   122.48 (+-0.01%)
BAC   23.34 (+0.00%)
BA   151.99 (+4.07%)
S&P 500   3,268.83 (+0.69%)
DOW   26,931.84 (+0.43%)
QQQ   267.95 (+0.96%)
AAPL   110.17 (+1.80%)
MSFT   206.05 (+1.41%)
FB   250.29 (+0.30%)
GOOGL   1,424.10 (+0.09%)
AMZN   3,040.11 (+0.67%)
TSLA   402.17 (+3.71%)
NVDA   504.79 (+2.20%)
BABA   267.86 (-0.69%)
CGC   14.06 (-1.47%)
GE   6.07 (+0.17%)
MU   48.31 (-2.34%)
AMD   76.59 (+1.02%)
T   27.86 (-0.64%)
F   6.54 (-1.80%)
ACB   5.00 (-3.85%)
GILD   61.92 (-0.53%)
NFLX   476.35 (+0.69%)
DIS   122.48 (+-0.01%)
BAC   23.34 (+0.00%)
BA   151.99 (+4.07%)
Log in
NYSE:GTH

Legend Biotech Stock Forecast, Price & News

$9.71
+0.61 (+6.70 %)
(As of 09/25/2020 12:33 PM ET)
Add
Compare
Today's Range
$9.35
Now: $9.71
$9.71
50-Day Range
$10.20
MA: $12.33
$14.08
52-Week Range
$9.03
Now: $9.71
$17.71
Volume698 shs
Average Volume307,021 shs
Market Capitalization$858.00 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services through laboratory developed tests services, such as HCCscreen, a proprietary assay for the early screening of liver cancer. It also provides in-vitro diagnostics products, including 8-gene Lung Cancer Assay, an IVD assay product based on semiconductor sequencing to detect lung cancer; Genetron 3D biochip reading instrument; IDH1/TERT gene assays for glioma; GENETRON S5, a semiconductor sequencer used in the field of gene detection; and Genetron S2000 that enables gene panel sequencing. In addition, the company develops ctDNA Lung Cancer assay for mutations in the epidermal growth factor receptor gene. It also offers development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies, hospitals, and research institutions worldwide. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.70 out of 5 stars


Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone86 10 5090 7500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees697
Market Cap$858.00 million
Next Earnings DateN/A
OptionableNot Optionable
$9.71
+0.61 (+6.70 %)
(As of 09/25/2020 12:33 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GTH News and Ratings via Email

Sign-up to receive the latest news and ratings for GTH and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Legend Biotech (NYSE:GTH) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Legend Biotech?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Legend Biotech in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Legend Biotech
.

How were Legend Biotech's earnings last quarter?

Legend Biotech Corporation (NYSE:GTH) posted its quarterly earnings data on Thursday, August, 6th. The company reported ($0.23) earnings per share (EPS) for the quarter. The business had revenue of $14.40 million for the quarter.
View Legend Biotech's earnings history
.

What price target have analysts set for GTH?

2 Wall Street analysts have issued 1-year price targets for Legend Biotech's shares. Their forecasts range from $19.00 to $20.00. On average, they expect Legend Biotech's share price to reach $19.50 in the next year. This suggests a possible upside of 100.8% from the stock's current price.
View analysts' price targets for Legend Biotech
.

Who are some of Legend Biotech's key competitors?

What other stocks do shareholders of Legend Biotech own?

Who are Legend Biotech's key executives?

Legend Biotech's management team includes the following people:
  • Mr. Sizhen Wang, Co-Founder, CEO & Director (Age 43)
  • Dr. Hai Yan, Co-Founder, Chief Scientific Officer & Director (Age 52)
  • Mr. Evan Ce Xu, Chief Financial Officer (Age 39)
  • Mr. Ying Hong, Chief Operating Officer (Age 48)
  • Dr. Yuchen Jiao M.D., Ph.D., Chief Technology Officer (Age 43)

When did Legend Biotech IPO?

(GTH) raised $162 million in an initial public offering (IPO) on Friday, June 19th 2020. The company issued 13,000,000 shares at a price of $11.50-$13.50 per share. Credit Suisse and CICC served as the underwriters for the IPO and BTIG and Canaccord Genuity were co-managers.

What is Legend Biotech's stock symbol?

Legend Biotech trades on the New York Stock Exchange (NYSE) under the ticker symbol "GTH."

When does the company's lock-up period expire?

Legend Biotech's lock-up period expires on Wednesday, December 16th. Legend Biotech had issued 16,000,000 shares in its public offering on June 19th. The total size of the offering was $256,000,000 based on an initial share price of $16.00. Shares of the company owned by company insiders and major shareholders will be eligible for trade following the end of the lock-up period.

How do I buy shares of Legend Biotech?

Shares of GTH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Legend Biotech's stock price today?

One share of GTH stock can currently be purchased for approximately $9.71.

How big of a company is Legend Biotech?

Legend Biotech has a market capitalization of $858.00 million. Legend Biotech employs 697 workers across the globe.

What is Legend Biotech's official website?

The official website for Legend Biotech is www.genetronhealth.com.

How can I contact Legend Biotech?

The company can be reached via phone at 86 10 5090 7500.

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.